Commercial Readiness Survey | Discovery to Demand

01

Strategic clarity

Is the development program anchored to a defined product and decision?

1. How clearly is the initial customer, crop, problem, and use pattern defined? Broad concept; the first customer and use are still open Priority segments have been proposed but not tested A primary segment and use pattern are defined The segment and use pattern are supported by customer and field evidence

2. Does the team use a target product profile with measurable advancement criteria? No target product profile Informal expectations exist but are not measurable A documented profile guides development The profile includes technical, regulatory, economic, and commercial thresholds

02

Evidence and product performance

Can the data support a repeatable, meaningful, and defensible claim?

3. How repeatable is performance across commercially relevant environments? Activity is preliminary or inconsistent Positive results exist, but response drivers are unclear Performance is repeatable within defined conditions Response boundaries and predictors are characterized

4. Do trials measure outcomes that connect to customer economics? Trials mainly measure technical activity Yield or efficacy is measured without a clear value model Key agronomic and economic endpoints are included Endpoints quantify value for the grower, channel, or downstream buyer

5. Are product identity, quality, formulation, storage, and application variables controlled? Critical product variables are not consistently documented Specifications exist, but field linkage is incomplete Quality and handling controls support interpretation Product-level variables are linked to field performance and shelf life

03

Market and access

Is the opportunity reachable under real regulatory, customer, and channel conditions?

6. How well defined is the regulatory path for the initial market? Product category and requirements are uncertain A likely path is identified Requirements, data gaps, timing, and cost are mapped The program and claims are aligned to a confirmed regulatory strategy

7. Is market size based on reachable customers and realistic adoption? The estimate is based mainly on total crop area or industry value Some segmentation has been applied TAM, SAM, and SOM use explicit assumptions Assumptions are triangulated with customer, channel, price, and adoption evidence

8. What evidence shows customers will change current practice? Interest is based mainly on positive reactions to the concept Customer interviews identify a problem but not switching criteria Buying behavior, alternatives, and willingness to pay are understood Trials, pilots, partnerships, or purchases demonstrate commitment

04

Commercial execution

Can the organization convert evidence into adoption and measurable progress?

9. Is there a credible route to market with aligned channel economics? Route to market has not been selected Potential partners or channels are being explored Channel roles, support needs, pricing, and margins are defined Partners and launch capabilities have been validated

10. Are the next investment milestones tied to decisions and evidence? Spending is organized mainly around activity or annual plans Milestones exist but lack decision thresholds Funding is tied to evidence and advancement criteria Leadership uses explicit advance, redirect, partner, or stop decisions

Is the opportunity ready for the next investment decision?

Strategic clarity

Evidence and product performance

Market and access

Commercial execution

Where focused work can help